Cultural values may explain low vaccination rates for diabetic minorities

February 05, 2003

Minorities with diabetes are less likely to be vaccinated for the flu and pneumonia than whites are -- even when they have equal healthcare access, insurance and socioeconomic status, a new study finds. Cultural values held by minorities as well as healthcare providers may help explain this, the researchers say.

"A better understanding of how differences in the cultural beliefs and values of healthcare providers and patients influence recommendation of services by providers and acceptance of health services by patients" is necessary, according to study author Leonard E. Egede, M.D., M.S., of the Department of Medicine at the Medical University of South Carolina in Charleston.

Currently "there are missed opportunities for vaccination of individuals with diabetes in primary care settings, particularly minority individuals," he adds.

Diabetes is more common among minorities, and African-Americans and Hispanics with this chronic disease have higher death rates and suffer more complications than whites do. Because having diabetes increases vulnerability to the flu and pneumonia, current guidelines recommend flu and pneumonia shots for diabetics.

Egede and study co-author Deyi Zheng Ph.D., M.B., from the Medical University of South Carolina's Department of Biometry and Epidemiology examined data on 1,906 diabetic adults. The researchers gathered the information from the National Health Interview Survey, a household survey sponsored by the National Center for Health Statistics.

Approximately half of the diabetic adults had received a flu shot, and 33 percent had received a pneumonia vaccine. The Healthy People 2010 target vaccination rate for diabetic adults younger than 65 is 65 percent.

"Regrettably, vaccination rates for people with diabetes are a long way from this objective," Egede notes. "There is a need to improve vaccination coverage in primary care settings."

Egede's and Zheng's main study finding was lower vaccination rates among African-Americans and Hispanics than whites, which could not be explained away by racial or ethnic differences in healthcare access, insurance coverage and socioeconomic status. This finding suggests racial and ethnic variations extend beyond a mere consideration of socioeconomics.

"We need to devote research efforts toward identifying the true reasons for the observed racial/ethnic disparities in vaccination rates for people with diabetes," Egede says. The study results are published in the February 2003 issue of the American Journal of Public Health.

The study authors suggest that more research on shared social and cultural values among racial and ethnic groups may help deepen the understanding of the racial and ethnic differences often noted in study findings.

"Future studies on the relationship between culture and health outcomes need to do more than merely demonstrate an association between cultural differences and health outcomes," Egede concludes. "They must provide a causal pathway for any such association."

This study was supported in part by grants from the Agency for Healthcare Research and Quality in Rockville, Md., and the Centers for Disease Control and Prevention, in Atlanta, Ga.
-end-
BY ANN QUIGLEY, CONTRIBUTING WRITER
HEALTH BEHAVIOR NEWS SERVICE

FOR MORE INFORMATION
Health Behavior News Service: 202-387-2829 or http://www.hbns.org.
Interviews: Contact Leonard E. Egede at egedel@musc.edu.
American Journal of Public Health: 202-777-2511 or http://www.ajph.org.

Center for Advancing Health

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.